Intrinsic Value of S&P & Nasdaq Contact Us

OrthoPediatrics Corp. KIDS NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
59/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$24.00
+34.4%

OrthoPediatrics Corp. (KIDS) is a Medical - Devices company in the Healthcare sector, currently trading at $17.86. It has a SharesGrow Score of 59/100, indicating a above average investment profile with 2 out of 7 criteria passed.

Analyst consensus target is KIDS = $24 (+34.4% upside).

Valuation: KIDS trades at a trailing Price-to-Earnings (P/E) of -9.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.29.

Financials: revenue is $236M, +24.9%/yr average growth. Net income is $40M (loss), growing at -617.5%/yr. Net profit margin is -16.8% (negative). Gross margin is 73.1% (-1 pp trend).

Balance sheet: total debt is $48M against $347M equity (Debt-to-Equity (D/E) ratio 0.14, conservative). Current ratio is 5.55 (strong liquidity). Debt-to-assets is 9.2%. Total assets: $523M.

Analyst outlook: 12 / 13 analysts rate KIDS as buy (92%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 96/100 (Pass), Growth 58/100 (Partial), Past 25/100 (Fail), Health 67/100 (Partial), Moat 54/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).

$24.00
▲ 34.38% Upside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for OrthoPediatrics Corp., the average price target is $24.00, with a high forecast of $34.00, and a low forecast of $18.00.
Highest Price Target
$34.00
Average Price Target
$24.00
Lowest Price Target
$18.00

KIDS SharesGrow Score Overview

59/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 96/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 54/100
Gross margin is + market cap
FUTURE 100/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — KIDS

VALUE Pass
96/100
KIDS trades at a trailing Price-to-Earnings (P/E) of -9.4 (S&P 500 average ~25). Forward PEG 0.29 — Peter Lynch undervalued (≤1.0). Analyst consensus target is $24, implying +34.4% from the current price $18. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
KIDS: +24.9%/yr revenue is, -617.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Fail
25/100
KIDS: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet KIDS: Debt-to-Equity (D/E) ratio 0.14 (conservative), Current ratio is 5.55 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
54/100
KIDS: Gross margin is 73.1% (-1 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 54/100. ≥ 70 = Pass.
View details →
FUTURE Pass
100/100
Analyst outlook: 12 / 13 analysts rate KIDS as buy (92%). Analyst consensus target is $24 (+34.4% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
10/100
KIDS: Net profit margin is -16.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range14.91-23.7
Volume176.66K
Avg Volume (30D)148.85K
Market Cap$451.48M
Beta (1Y)1.16
Share Statistics
EPS (TTM)-1.69
Shares Outstanding$23.46M
IPO Date2017-10-13
Employees562
CEODavid R. Bailey
Financial Highlights & Ratios
Revenue (TTM)$236.35M
Gross Profit$172.66M
EBITDA$-7.88M
Net Income$-39.65M
Operating Income$-29M
Total Cash$60.85M
Total Debt$48.36M
Net Debt$28.8M
Total Assets$523.08M
Price / Earnings (P/E)-10.6
Price / Sales (P/S)1.91
Analyst Forecast
1Y Price Target$23.50
Target High$34.00
Target Low$18.00
Upside+31.6%
Rating ConsensusBuy
Analysts Covering13
Buy 92% Hold 8% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS68752L1008

Price Chart

KIDS
OrthoPediatrics Corp.  ·  NASDAQ Global Market
Healthcare • Medical - Devices
14.91 52WK RANGE 23.70
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message